Financial Performance - For the year ended December 31, 2024, the total revenue increased to HKD 576,615,000, representing a growth of 68.7% compared to HKD 341,863,000 in 2023[4] - The gross profit for the same period was HKD 29,895,000, up from HKD 10,083,000 in 2023, indicating a significant improvement in profitability[4] - The company reported a profit attributable to equity holders of HKD 491,000, a turnaround from a loss of HKD 4,970,000 in the previous year[4] - Total revenue for the year ended December 31, 2024, was HKD 576,615,000, representing a 68.7% increase from HKD 341,863,000 in 2023[18] - The company reported a pre-tax profit of HKD 491,000 for 2024, a significant recovery from a loss of HKD 4,970,000 in 2023[27] - The company achieved a profit of HKD 0.5 million in fiscal year 2024, recovering from a net loss of HKD 5 million in fiscal year 2023[49] Revenue Breakdown - The distribution business segment generated revenue of HKD 52,085,000, while the supply chain business segment contributed HKD 524,530,000, highlighting the latter's dominance in overall revenue[13] - Revenue from the supply chain business was HKD 524,530,000, accounting for 91% of total revenue, while distribution business revenue was HKD 52,085,000[19] - Revenue from China (including Hong Kong and Macau) reached HKD 367,196,000, up 32.5% from HKD 277,166,000 in 2023[19] - The company reported a significant increase in revenue from Asia (excluding China) to HKD 175,514,000, compared to HKD 61,819,000 in 2023[19] - Supply chain business revenue increased by 84.3% to HKD 524.5 million in fiscal year 2024, up from HKD 284.6 million in fiscal year 2023[39] Assets and Liabilities - The total assets as of December 31, 2024, were HKD 373,742,000, compared to HKD 318,631,000 in 2023, reflecting a growth of 17.3%[5] - The net current assets decreased to HKD 123,135,000 from HKD 165,203,000, indicating a decline of 25.5%[5] - The company’s total equity as of December 31, 2024, was HKD 164,117,000, slightly down from HKD 165,329,000 in 2023[5] - Trade receivables increased to HKD 141,709,000 in 2024, compared to HKD 93,102,000 in 2023, indicating improved collection efficiency[29] - Inventory as of December 31, 2024, was HKD 72.4 million, an increase of HKD 31.8 million from HKD 40.6 million on December 31, 2023[50] - Trade payables rose to HKD 55.5 million as of December 31, 2024, an increase of HKD 25.7 million from HKD 29.8 million on December 31, 2023[52] Expenses and Costs - The financing costs decreased to HKD 3,133,000 from HKD 4,059,000, showing a reduction of 22.8%[4] - Sales and distribution expenses increased by 365.7% to HKD 4.2 million in fiscal year 2024, primarily due to increased sales activities[46] - Administrative expenses decreased by 5.2% to HKD 13.0 million in fiscal year 2024, mainly due to reduced legal and professional fees[47] Future Plans and Strategies - The company plans to expand its distribution business in Southwest China, aiming for increased sales contracts by 2025[59] - The company intends to develop long-term supply agreements in coal and traditional Chinese medicine products, targeting stable large-scale trade by 2025[61] - The company aims to expand its business team in the next 12 months to meet growing market demands[63] - The company is actively exploring green energy project investments in Yunnan Province and Southeast Asia, aiming to expand installed capacity and enhance revenue and profit contributions[64] - By 2025, the company plans to deepen its market presence in Southeast Asia, focusing on green energy project investments in Laos and Myanmar[65] - The company aims to leverage its parent company's overseas network to expand its supply chain business in South Asia and Southeast Asia by 2025[65] Corporate Governance and Compliance - The company has not yet applied new or revised international financial reporting standards that have been issued but not yet effective, indicating a potential future impact on financial reporting[11] - The audit committee has reviewed the group's financial performance and has no objections to the accounting principles adopted[74] - The company has not engaged in any buybacks or sales of its listed securities during the fiscal year 2024[73] Dividend Policy - The company did not recommend a final dividend for the year ended December 31, 2024, consistent with 2023[25] - The board does not recommend the payment of a final dividend for the fiscal year ending December 31, 2024[69]
云能国际(01298) - 2024 - 年度业绩